This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Rye Brook, NY, Xylem Inc. is one of the leading providers of water solutions worldwide. The company is involved in the full water-process cycle, including collection, distribution and returning of water to the environment. It has significant presence in the United States, the Asia Pacific, Europe and various other nations. The company reports business operations under three segmental heads — Water Infrastructure, Sensus and Applied Water.
Xylem Stock Exhibits Strong Prospects Despite Persisting Headwinds
by Zacks Equity Research
XYL is set to benefit from solid momentum across its M&CS, Water Infrastructure and Water Solutions and Services segments. However, rising costs remain a concern.
DXPE Stock Surges 113.5% in 6 Months: Should Investors Buy or Wait?
by Avisekh Bhattacharjee
DXP Enterprises is making strides in the key end markets, which makes the stock worth a watch amid certain headwinds.
Xylem's Q4 Earnings & Revenues Beat Estimates, Orders Up Y/Y
by Zacks Equity Research
XYL's fourth-quarter 2024 organic revenues increase 7% year over year, driven by the impressive performances of its Water Solutions and Services, Measurement & Control and Water Infrastructure units.
Xylem (XYL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Xylem (XYL) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Xylem (XYL) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 5.36% and 3.37%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Insights Into Xylem (XYL) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Xylem (XYL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Xylem Gears Up to Post Q4 Earnings: Here's What's in Store
by Zacks Equity Research
XYL's fourth-quarter results are likely to reflect the impacts of weakness in the Applied Water segment and input cost inflation. Strength in the M&CS segment is likely to have been a positive.
Waste Management (WM) Q4 Earnings Miss Estimates
by Zacks Equity Research
Waste Management (WM) delivered earnings and revenue surprises of -5.03% and 0.18%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DXP Enterprises is Trading Near 52-Week High: Should You Buy the Stock?
by Avisekh Bhattacharjee
DXPE's strength across its end markets, solid backlog level and accretive buyouts make it an attractive pick for investors.
Should You Invest in the Invesco S&P Global Water Index ETF (CGW)?
by Zacks Equity Research
Sector ETF report for CGW
Concrete Pumping (BBCP) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Concrete Pumping (BBCP) delivered earnings and revenue surprises of 14.29% and 1.26%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Xylem Boosts Portfolio With Acquisition of Majority Stake in Idrica
by Zacks Equity Research
The acquisition of a majority stake in Idrica is set to enable XYL to penetrate new markets and deliver intelligent solutions to its customers.
Here's Why You Should Avoid Investing in Xylem Stock Right Now
by Zacks Equity Research
XYL experiences weakness in its operations due to softness in the Applied Water segment. Rising costs are added concerns.
Should You Invest in the Invesco S&P Global Water Index ETF (CGW)?
by Zacks Equity Research
Sector ETF report for CGW
Xylem's Q3 Earnings Meet Estimates, Revenues Miss, Orders Up Y/Y
by Zacks Equity Research
XYL's third-quarter 2024 organic revenues increase 1% year over year, driven by the impressive performances of its Measurement & Control and Water Infrastructure segments.
Here's What Key Metrics Tell Us About Xylem (XYL) Q3 Earnings
by Zacks Equity Research
Although the revenue and EPS for Xylem (XYL) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Xylem (XYL) Q3 Earnings Meet Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 0% and 3.31%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Amcor Gears Up to Report Q1 Earnings: What Should You Expect?
by Zacks Equity Research
AMCR Q1 earnings are expected to have gained from a pick-up in volumes and price mix.
Ingersoll Rand Gears Up to Post Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
IR's third-quarter results are likely to gain from strength across the Industrial Technologies & Services and Precision and Science Technologies segments.
Standex International (SXI) Q1 Earnings Top Estimates
by Zacks Equity Research
Standex (SXI) delivered earnings and revenue surprises of 3.01% and 4.76%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Is a Beat in Store for Parker-Hannifin This Earnings Season?
by Zacks Equity Research
PH's fiscal Q1 results are likely to gain from strength in the commercial and military end markets. Weakness in the off-highway and transportation end markets is likely to have been a woe.
Xylem (XYL) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Xylem (XYL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
Chart Industries (GTLS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Chart Industries (GTLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Xylem (XYL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Xylem (XYL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.